Early Access

10-KPeriod: FY1995

BECTON DICKINSON & CO Annual Report, Year Ended Sep 30, 1995

Filed December 27, 1995For Securities:BDX

Summary

BECTON DICKINSON & CO (BDX) filed its 1995 Annual Report (10-K) on December 27, 1995, covering the period ending September 29, 1995. This filing provides a snapshot of the company's financial health and operational performance for the fiscal year. While specific financial figures and detailed operational discussions are not present in the provided snippet, the filing itself signifies BD's commitment to transparent reporting for its investors. Investors should look to the full 10-K document for crucial details on revenue, profitability, cash flows, balance sheet strength, and management's outlook. Key areas of focus for investors would typically include revenue growth across its various business segments, profitability margins, debt levels, and any significant capital expenditures or strategic initiatives undertaken during the year. The nature of BDX's business in medical technology and devices suggests a focus on innovation, regulatory compliance, and market penetration as drivers of performance.

Key Highlights

  • 1BDX filed its 1995 10-K annual report on December 27, 1995.
  • 2The reporting period concluded on September 29, 1995.
  • 3The filing is a standard disclosure for publicly traded companies to provide investors with financial and operational information.
  • 4This report covers BD's performance for the fiscal year 1995.
  • 5Investors can find detailed financial statements, management discussion and analysis (MD&A), and risk factors within the full report.
  • 6The document is a key resource for understanding the company's financial position and strategic direction at that time.

Frequently Asked Questions